Core Viewpoint - Nanjing Weisi Medical Technology Co., Ltd. has announced its 2025 restricted stock incentive plan, detailing the allocation of shares to various executives and key personnel, aimed at motivating and retaining talent within the company [1]. Summary by Relevant Sections Incentive Plan Allocation - The total number of restricted shares granted under the incentive plan is 96.80 million shares, which constitutes 20.00% of the company's total share capital [1]. - The allocation includes shares for the chairman, general manager, and core technical personnel, with specific amounts detailed for each individual [1]. Individual Allocations - Wang Zhiyu (Chairman and General Manager) is allocated 6.00 million shares, representing 6.20% of the total shares granted [1]. - Other key executives, such as Zhong Yiqun and Chen Lili (both Deputy General Managers), are allocated 3.50 million shares each, accounting for 3.62% of the total shares granted [1]. - The total allocation for other personnel deemed necessary for motivation is 54.86% of the total shares granted, with a reserve of 9.60 million shares [1]. Compliance and Disclosure - The company will disclose relevant information regarding the incentive plan in accordance with legal requirements after obtaining professional opinions from lawyers [2].
伟思医疗: 南京伟思医疗科技股份有限公司2025年限制性股票激励计划首次授予激励对象名单(截至授予日)